Singapore: Human Metabolome Technologies (HMT), the leading provider of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technology, announced the opening of its first US office in Cambridge.

The location of the office was based largely in part by the accessibility for globally competitive pharmaceutical companies and research institutions to HMT's most important metabolome analysis services, CARCINOSCOPE, which was specifically designed for cancer research, and BASIC SCAN for more global, general-purpose metabolomics research including biomarker discovery and companion diagnostics.

"Cambridge provides the perfect combination of academic and industrial arenas especially associated with the field of life science, food engineering, and environmental studies," said Tsutomu Hoshiba, president, HMT America.

"HMT provides cutting-edge solutions to life scientists, medical doctors, and pharmacologists via our state-of-the-art metabolomics technology based on capillary electrophoresis mass spectrometry (CE-MS), and we believe that Cambridge is the place to be for networking with businesses that will make the most of our solutions," Hoshiba added.